Eight Blood Molecules Link Air Pollution to Lung Cancer

Eight small molecules found in blood link air pollution to lung cancer, years before the disease is diagnosed, according to a study published on August 11, 2026 in the journal Nature Communications. The research was led by scientists from the American Cancer Society and Emory University’s Rollins School of Public Health, with Sabrina S. Chou as first author. The team analyzed blood samples from people who had no cancer diagnosis at the time the samples were drawn.

Epidemiology has long shown that prolonged exposure to dirty air raises the risk of lung cancer. What has stayed unclear is what happens inside the body in the meantime, that is, which biochemical steps connect exposure to disease. This study sets out to fill exactly that gap.

“Outdoor air pollution has been classified as a human carcinogen, and in epidemiological studies, its association with lung cancer is often strongest among people who have never smoked.”

That is what Jing Wang, senior principal scientist for epidemiology research at the American Cancer Society and one of the study’s two senior authors, said in a statement announcing the findings. “This tells us something important is happening biologically, but we still don’t understand the mechanisms,” she added.

How the study was conducted

The analysis included 1,357 participants drawn from the Cancer Prevention Study cohorts, a long running American research effort that has tracked the health of large groups of people over decades. Blood was drawn from all of them while they were still healthy, and some of them went on to develop lung cancer years later.

Each sample was tested for more than 1,100 metabolites, small molecules produced by metabolism that circulate in the blood. Their combined makeup is known as the metabolome, and it shifts with diet, habits and whatever a person breathes in. Pollution levels were estimated from each participant’s home address on the day their blood was drawn, factoring in airborne particulates, ozone and traffic exhaust.

Comparing the blood of those who later became ill with the blood of those who stayed healthy singled out eight metabolites tied to both the exposure and the later disease. Four of them were found to mediate the link between the pollutants and lung cancer. Four metabolic pathways were affected:

• inflammation
• oxidative stress
• detoxification
• energy metabolism

Some of the flagged compounds are tied to the body’s antioxidant defenses. Others relate to the breakdown of furans, a toxic byproduct of burning fuel, wood and tobacco, raising the question of whether traffic and industrial emissions leave a mark inside the body similar to that of tobacco. The finding remained statistically significant even after accounting for participants’ smoking status.

Why does it matter who falls outside screening?

Lung cancer is the leading cause of cancer death in the United States, where regular screening is recommended only for adults between 50 and 80 with a substantial smoking history. People who never smoked are, as a rule, not screened.

“While smoking is a key risk factor for lung cancer, more than half of lung cancer cases are diagnosed in people who never smoked or who smoked but do not meet the criteria for lung cancer screening.”

That is what Donghai Liang, associate professor of environmental health at the Rollins School of Public Health and the study’s other senior author, said in the same statement. Understanding risk factors unrelated to smoking, such as air pollution, matters for cancer prevention and early detection, he said.

“What is particularly exciting about this study is that we have now identified measurable changes in the human blood metabolome associated with air pollution exposure, years before lung cancer was diagnosed.”

What this study does not prove

The study is observational. It shows that exposure, changes in the blood and later disease are linked, but it does not prove that air pollution causes lung cancer through those specific molecules. The authors themselves describe their findings as hypothesis generating, not as final proof.

The sample is also a bottleneck of the study. Participants were mostly older and white, so the authors explicitly call for validation in more diverse populations before drawing any conclusion about broader applicability. Eight metabolites do not amount to a test someone could run in a lab tomorrow, since that would require independent replication in other cohorts and proof that the marker predicts disease better than the information a doctor already has.

What remains is a measurable trace. Until now, studies like this measured air on the street. Now it has been measured in blood too.